Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Paolo Corradini Francesco Spina |
| Publication date | September 25, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |